These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8862446

  • 1. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.
    Neff T, Blau CA.
    Exp Hematol; 1996 Sep; 24(11):1340-6. PubMed ID: 8862446
    [Abstract] [Full Text] [Related]

  • 2. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N, Cournoyer D, Momparler RL.
    Cancer Chemother Pharmacol; 1998 Sep; 42(5):373-8. PubMed ID: 9771951
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL, Eliopoulos N, Bovenzi V, Létourneau S, Greenbaum M, Cournoyer D.
    Cancer Gene Ther; 1996 Sep; 3(5):331-8. PubMed ID: 8894252
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
    Létourneau S, Palerme JS, Delisle JS, Beauséjour CM, Momparler RL, Cournoyer D.
    Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM, Pinedo HM, Jongsma AP, Brouwer M, Ruiz van Haperen VW, Veerman G, Leyva A, Eriksson S, Peters GJ.
    Biochem Pharmacol; 1999 Feb 15; 57(4):397-406. PubMed ID: 9933028
    [Abstract] [Full Text] [Related]

  • 9. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
    Bergman AM, Munch-Petersen B, Jensen PB, Sehested M, Veerman G, Voorn DA, Smid K, Pinedo HM, Peters GJ.
    Biochem Pharmacol; 2001 Jun 01; 61(11):1401-8. PubMed ID: 11331076
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.
    Beauséjour CM, Gagnon J, Primeau M, Momparler RL.
    Biochem Biophys Res Commun; 2002 May 24; 293(5):1478-84. PubMed ID: 12054682
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside.
    Sauerbrey A, McPherson JP, Zhao SC, Banerjee D, Bertino JR.
    Hum Gene Ther; 1999 Oct 10; 10(15):2495-504. PubMed ID: 10543614
    [Abstract] [Full Text] [Related]

  • 14. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice.
    Eliopoulos N, Bovenzi V, Le NL, Momparler LF, Greenbaum M, Létourneau S, Cournoyer D, Momparler RL.
    Gene Ther; 1998 Nov 10; 5(11):1545-51. PubMed ID: 9930308
    [Abstract] [Full Text] [Related]

  • 15. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N, Al-Khaldi A, Beauséjour CM, Momparler RL, Momparler LF, Galipeau J.
    Gene Ther; 2002 Apr 10; 9(7):452-62. PubMed ID: 11938460
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.
    Schröder JK, Kirch C, Flasshove M, Kalweit H, Seidelmann M, Hilger R, Seeber S, Schütte J.
    Leukemia; 1996 Dec 10; 10(12):1919-24. PubMed ID: 8946931
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application.
    Brennig S, Rattmann I, Lachmann N, Schambach A, Williams DA, Moritz T.
    Cytotherapy; 2012 Apr 10; 14(4):451-60. PubMed ID: 22242831
    [Abstract] [Full Text] [Related]

  • 20. Forced expression of cytidine deaminase confers sensitivity to capecitabine.
    Morita T, Matsuzaki A, Kurokawa S, Tokue A.
    Oncology; 2003 Apr 10; 65(3):267-74. PubMed ID: 14657601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.